UNI MEDICAL Reports Stable Share Capital in July 2026 and Confirms Public Float Compliance

Bulletin Express08-06

Genertec Universal Medical Group Company Limited (UNI MEDICAL) filed its monthly return to Hong Kong Exchanges and Clearing Limited for the period ended 31 July 2026, disclosing no movements in share capital or treasury shares.

The number of issued ordinary shares remained unchanged at 2.01 billion, with zero treasury shares recorded. As a result, total issued shares at month-end also stood at 2.01 billion.

UNI MEDICAL affirmed that the public float exceeded the Main Board’s Initial Prescribed Threshold of 25 percent, meeting all listing-rule requirements.

Under the company’s share option scheme approved on 31 December 2019, total capacity is capped at 171.63 million shares. Outstanding options were nil at the end of July, leaving 155.57 million shares available for future grants. No shares were issued, no treasury shares were transferred, and no proceeds were raised during the month.

The filing further confirmed there were no outstanding warrants, convertible securities, or other agreements that could dilute share capital. All regulatory confirmations required under Main Board Rule 13.25C were provided by Executive Director Chen Shisu on 6 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1133324273?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-06 17:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133324273","market":"us","top_or_hot":-1,"title":"UNI MEDICAL Reports Stable Share Capital in July 2026 and Confirms Public Float Compliance","media":"Bulletin Express","content":"<p>Genertec Universal Medical Group Company Limited (UNI MEDICAL) filed its monthly return to Hong Kong Exchanges and Clearing Limited for the period ended 31 July 2026, disclosing no movements in share capital or treasury shares.</p>\n<p>The number of issued ordinary shares remained unchanged at 2.01 billion, with zero treasury shares recorded. As a result, total issued shares at month-end also stood at 2.01 billion.</p>\n<p>UNI MEDICAL affirmed that the public float exceeded the Main Board’s Initial Prescribed Threshold of 25 percent, meeting all listing-rule requirements.</p>\n<p>Under the company’s share option scheme approved on 31 December 2019, total capacity is capped at 171.63 million shares. Outstanding options were nil at the end of July, leaving 155.57 million shares available for future grants. No shares were issued, no treasury shares were transferred, and no proceeds were raised during the month.</p>\n<p>The filing further confirmed there were no outstanding warrants, convertible securities, or other agreements that could dilute share capital. All regulatory confirmations required under Main Board Rule 13.25C were provided by Executive Director Chen Shisu on 6 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UNI MEDICAL Reports Stable Share Capital in July 2026 and Confirms Public Float Compliance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUNI MEDICAL Reports Stable Share Capital in July 2026 and Confirms Public Float Compliance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-06 17:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Genertec Universal Medical Group Company Limited (UNI MEDICAL) filed its monthly return to Hong Kong Exchanges and Clearing Limited for the period ended 31 July 2026, disclosing no movements in share capital or treasury shares.</p>\n<p>The number of issued ordinary shares remained unchanged at 2.01 billion, with zero treasury shares recorded. As a result, total issued shares at month-end also stood at 2.01 billion.</p>\n<p>UNI MEDICAL affirmed that the public float exceeded the Main Board’s Initial Prescribed Threshold of 25 percent, meeting all listing-rule requirements.</p>\n<p>Under the company’s share option scheme approved on 31 December 2019, total capacity is capped at 171.63 million shares. Outstanding options were nil at the end of July, leaving 155.57 million shares available for future grants. No shares were issued, no treasury shares were transferred, and no proceeds were raised during the month.</p>\n<p>The filing further confirmed there were no outstanding warrants, convertible securities, or other agreements that could dilute share capital. All regulatory confirmations required under Main Board Rule 13.25C were provided by Executive Director Chen Shisu on 6 August 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02666","symbol_name":"环球医疗","start_time":0,"source_url":"","article_id":"1133324273","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133324273","pubTimestamp":1786007044,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Genertec Universal Medical Group Company Limited (UNI MEDICAL) filed its monthly return to Hong Kong Exchanges and Clearing Limited for the period ended 31 July 2026, disclosing no movements in share...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02666":"环球医疗"},"translate_title":"UNI MEDICAL 报告 2026 年 7 月股本稳定并确认符合公开发行要求","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02666":1},"content_text":"Genertec Universal Medical Group Company Limited (UNI MEDICAL) filed its monthly return to Hong Kong Exchanges and Clearing Limited for the period ended 31 July 2026, disclosing no movements in share capital or treasury shares.\nThe number of issued ordinary shares remained unchanged at 2.01 billion, with zero treasury shares recorded. As a result, total issued shares at month-end also stood at 2.01 billion.\nUNI MEDICAL affirmed that the public float exceeded the Main Board’s Initial Prescribed Threshold of 25 percent, meeting all listing-rule requirements.\nUnder the company’s share option scheme approved on 31 December 2019, total capacity is capped at 171.63 million shares. Outstanding options were nil at the end of July, leaving 155.57 million shares available for future grants. No shares were issued, no treasury shares were transferred, and no proceeds were raised during the month.\nThe filing further confirmed there were no outstanding warrants, convertible securities, or other agreements that could dilute share capital. All regulatory confirmations required under Main Board Rule 13.25C were provided by Executive Director Chen Shisu on 6 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1133324273","isCrawlerRequest":true}